20 Best PhD Scholarships in the world : Fully funded

Do you want to secure a fully funded PhD Scholarship?

Here are the top 20 PhD scholarships with their respective website links.

1.Fulbright Program : https://lnkd.in/dbK8i6Pw

2.Chevening Scholarships : https://www.chevening.org/

3.Erasmus Mundus Joint Doctorates : https://lnkd.in/dfhjg4GC

4.Gates Cambridge Scholarship : https://lnkd.in/dNdubBt7

5.Rhodes Scholarship : https://lnkd.in/dWxCZ8Za

6.Marie Skłodowska-Curie Actions (MSCA) : https://lnkd.in/dAkq7QSX

7.Commonwealth Scholarship and Fellowship Plan : https://lnkd.in/dnCW5gQa

8.DAAD Scholarships : https://lnkd.in/dwZyr_X8

9. Erasmus+ Joint Doctorate Program : https://lnkd.in/dRknG_h6

10.Australia Awards Scholarships : https://lnkd.in/dY2qWBBb

11.Schwarzman Scholars Program : https://lnkd.in/dkSgbBmy

12.Swiss Government Excellence Scholarships : https://lnkd.in/d3HvNMQc

13.Chinese Government Scholarships : https://lnkd.in/djqxFBp8

14.Endeavour Postgraduate Awards : https://www.strath.ac.uk/

15.Japanese Government Scholarships : https://lnkd.in/deMU8MJW

16.Ford Foundation International Fellowships Program : https://lnkd.in/dZzaYBYp

17.Soros Fellowships for New Americans : https://www.pdsoros.org/

18.Korean Government Scholarship Program : https://lnkd.in/dBUDgJzZ
 
19.Netherlands Government Scholarship Program : https://www.uaf.nl/

20. Vanier Canada Graduate Scholarships : https://lnkd.in/duZm4qQf 

A to Z about Fake/Predatory Journals : Tips for scholars

Thank you for visiting my blog...!!!

There are lakhs of journals available online and we may often get confused which one to choose. Many a times researchers end up publishing in a predatory/fake journals for many reasons. Here is how to choose wisely. This article will help you how to identify a scholarly journal over a predatory/fake journal. 

A predatory journal bluffs the readers with these basic characteristics :

Peer review: Claims of making a thorough peer review process, but there is no evidence that any peer review is carried out. There is no evidence of selectivity or screening based on editorial or quality checks as all submissions appear to be accepted. As well as advertising peer review, these journals often offer very rapid peer review times of under a week or rapid peer review service where additional payments can be made for a faster decision.

Editors/ Editorial board: The editorial boards of deceptive journals often feature people who have not consented to be on the board. The members may not be discoverable at the affiliations listed in their board entries. For publishers with multiple journals, individuals may be featured on the boards of a large number of titles, some of which may not be in similar fields.

Affiliation: Similar to the co-opting of individuals, predatory journals may also state or imply they are affiliated with prestigious institutions and organisations, without their knowledge or consent.

Indexing databases: Predatory journals often attempt to give the impression they are indexed in the key journal indexes Web of Science and Scopus, through outright false claims or by deceptive means. Predatory databases share names very similar to the official mainstream sites such as Index Scientific Journals, which can use the acronym ISI to match the real ISI Web of Science. Therefore, a journal can claim to be listed in ISI, but refer to the pay-per-listing site, rather than the real site (which is free but has strict inclusion criteria). 

These databases likely use Google Scholar to draw their citation metrics from – if they base them on anything at all. Their sources and methods are not usually explained or transparent. Inclusion in these databases is granted in exchange for a fee, with an ‘Impact Factor’ provided for an additional fee, so there is no barrier to inclusion other than a fee. Some journals use these databases to list themselves and present as being indexed in prestigious, valuable scientific databases. For example, presenting sites such as ResearchGate and Mendeley as indexing databases, or claiming Thomson Reuter Researcher IDs, Scopus Researcher IDs and ORCiD accounts in the name of a journal.

Journal Metrics: The deceptive practices around metrics follow a similar theme to index databases. Through receiving metric awards from predatory databases, journals can make claims of having high ‘Impact Factors’. It is important to note that there is only one legitimate ‘Impact Factor’ - the Journal Impact Factor (JIF), awarded to journals indexed in the Web of Science, owned by Clarivate Analytics.

Deceptive journals may also have very high self-citation rates to inflate their Google Scholar citation metrics. There are also journals indexed in Scopus and Web of Science that succeed in being indexed with relatively low citation counts, and then display large increases in citations, all powered through self-citations. These are visible in the Scopus SJR database.

Location: The locations or offices of deceptive journals or publishers are quite often not mentioned anywhere on a website. If they are mentioned, the address is usually in the United States or UK. However, the Editorial Boards and author locations of the individuals listed in the journal site indicate other locations. In some cases, where postcodes/zipcodes are provided, these can be put into Google Maps and searched and can yield surprising or amusing results.

Identifying Predatory Journals: Some things to look out for
1.Poor and unprofessional looking website
2.Charging exorbitant fees for publication of articles
3.Lack of peer-review or editorial oversight.
4.Listing academics as members of editorial boards without their permission or listing fake scholars as members of editorial boards or authors.
5.The journal defines no clear publication date.
6.The journal’s contact email address is non-professional and non-journal affiliated (e.g. @gmail.com or @yahoo.com).
7.The journal sends open calls/unsolicited emails to many authors to invite them to submit papers to them.
8.Fake, non-existent, or misrepresented impact factors.
9.The journal is not read or known by your colleagues or peers.

Tactic	How to Recognize
Solicitation	Suspect journals aggressively solicit scholars to submit papers.  The solicitation may come as spam or individual emails. Legitimate journals usually do not solicit authors but instead have the authors contact them. The journal agrees to publish your article for a fee before reviewing it.
Peer Review	A claim that a journal is peer reviewed is not enough. Almost all predatory journals claim to be peer reviewed.  The stated time for peer review is extremely short. You are asked whom you would like to review your work.
Impact Factors	Be wary of journals that cite bogus impact factors, such as the GIF ( Global Impact Factor), Index Copernicus Value, Citefactor, or the UIF (Universal Impact Factor). Some may falsify legitimate impact factors. Impact Factors can be verified via Web of Science, Dimensions or Google.
Editorial Board	Members of the editorial board lack qualifications in the field. Different  journals by the same publisher have the same editorial board. Predatory journals will sometimes  solicit well-known scholars to join their boards in order to lend credibility to their journal but don't let them make decisions. (How you would make this discovery even with good due diligence is hard to imagine.) Listing academics as members of editorial boards without their permission and not allowing academics to resign from editorial boards.
Indexing	The journal is not indexed in the major indexes in the field as well as general indexes, even though it might claim to be. Some journals falsely claim to be indexed by Thomson Reuters.
Watch lists	The journal is listed on Beall's List of Predatory Journals, Cabell's Predatory Journals list, or other watchlist.
Other Factors	The journal is difficult to locate in library catalogs, i.e. few major libraries subscribe to it.  The scope is overly broad and/or does not fit well with your research. Publication frequency is irregular or not stated. May have the same or similar name to a legitimate journal. The former is characteristic of hijacked journals. The email address is often non-professional, e.g.,  (@yahoo.com, ao.com or @gmail.com).

Risks involved in publishing in fake/predatory journals :

• Publishing in a predatory journal could damage your credibility and the credibility of your research.
• Predatory publishers have no interest in helping to withdraw your article and may use any request as leverage to charge further fees.
• Your profile will be exploited eg. by adding your name to lists of editors, even if you haven’t agreed.
• You lose the opportunity to publish your research in a credible journal.
• Monetary costs for the author/ institutions.
• Reputational costs for the author/ institutions.
• Negative impact on ranking and research assessment.
• No assurance of longevity of the paper.
• Possible legal consequences

Good News for PharmD Graduates in India : Guess what??

Dear Readers, Thank you for blogging with us..!!!

I'm glad to share this great news with you, upon consistent efforts of the Association for Doctor of Pharmacy (ADP), PharmD Doctor's Welfare Association (PWDA) and all other PharmD associations, since years in India, we have moved way forward in achieving a great milestone in the career path.

Introduction: In recent times, governments around the world have acknowledged the significance of healthcare professionals and the evolving nature of the pharmaceutical industry. As a testament to their commitment to enhancing public health, many governments have taken a commendable step by including Doctor of Pharmacy (PharmD) as an eligibility criterion for various government positions. This progressive decision not only recognizes the unique expertise possessed by PharmD graduates but also ensures the provision of quality healthcare services to the citizens. In this blog, we will delve into the reasons why this move is worthy of appreciation. 

You might have aware that Central Research Institutes/Organizations like the Indian Council of Medical Research (ICMR), Department of Health Research (DHR), Ministry of Health and Family Welfare (MoHFW), Government of India (GoI); Indian Institute of Chemical Technology (IICT), Council of Scientific and Industrial Research (CSIR); Center for Cellular and Molecular Biology (CCMB); Department of Science and Technology (DST); Department of Biotechnology (DBT) etc., and autonomous grant-in-aid institutions like Tata Memorial Centre (TMC), Department of Atomic Energy (DAE), Government of India (GoI) have offered several temporary scientific positions and fellowships for PharmD graduates considering our clinical and scientific skills. I personally was shortlisted for more than 5 Scientific positions (Scientist-B, Scientist-C, Scientist -D, Scientific Consultant, Associate Consultant) etc., in such research organizations. 

Enhancing Healthcare Delivery: The inclusion of PharmD as an eligibility criterion for research and scientific positions demonstrates a proactive approach to improving healthcare delivery. Pharmacists play a crucial role in healthcare teams, acting as medication experts and providing valuable insights into drug therapy. With their specialized training in pharmaceutical sciences, pharmacokinetics, and therapeutics, PharmD graduates possess a deep understanding of drug-related issues and can effectively contribute to medication safety initiatives. By including PharmD graduates in such government positions, their extensive knowledge and skills, enhance the quality of healthcare services, help minimize adverse drug reactions, prevent medication errors, and promote optimal drug utilization, ultimately safeguarding the well-being of the public. The ability of pharmacists to analyze complex medication regimens, manage drug interactions, and offer patient counseling contributes significantly to improving patient outcomes.

Healthcare Policy Development: Government positions often involve policy-making and strategic planning for healthcare systems. Including PharmD graduates in these roles brings a unique perspective to the table. PharmD graduates are trained not only in clinical pharmacy but also in areas such as pharmacoeconomics, health outcomes research, and health policy. Their comprehensive understanding of the pharmaceutical industry allows them to contribute to evidence-based decision-making, drug pricing policies, and healthcare cost containment strategies. The inclusion of PharmD as an eligibility criterion thus enriches the pool of professionals involved in shaping healthcare policies, leading to more informed and effective strategies.

News for today: Indian Council of Medical Research (ICMR) has released a memorandum amending Rule No. 14 and Schedule III of the ICMR, HSRC rules, 2007 communicated by DHR to inlude PharmD as eligibility criteria for various scientific positions along with other graduate and post-graduate qualifications. 

• Scientist - B with Pay level 10 (Rs. 56100-177500) Pre-revised GP: Rs. 5400/-
• Scientist - C with Pay level 11 (Rs. 67700-208700) Pre-revised GP: Rs. 6600/-
• Scientist - D with Pay level 12 (Rs. 78800-209200) Pre-revised GP: Rs. 7600/-
• Scientist - E with Pay level 13 (Rs. 123100-215900) Pre-revised GP: Rs. 8700/-
• Scientist - F with Pay level 13A (Rs. 131100-216600) Pre-revised GP: Rs. 8900/-
• Scientist - G with Pay level 14 (Rs. 144200-218200) Pre-revised GP: Rs. 10000/-

The complete document can be accessed through this weblink: HSRC amendment rules - PharmD

Health Technology Assessment in India (HTAIn) and DHR ICMR Advanced Molecular Oncology Diagnostic Services (DIAMOnDS), Department of Health Research (DHR), Ministry of Health and Family Welfare (MoHFW). Government of India (GoI) has identified the following  institutes as Technical Partners of HTAIn, so far, with a physical target of 125 scientific projects.

1. All India Institute of Medical Sciences (AIIMS), New Delhi.
2. National Institute of Medical Statistics (NIMS), New Delhi
3. National Health Systems Resource Centre (NHSRC), New Delhi
4. Public Health Foundation of India (PHFI), New Delhi
5. Institute of Economic Growth (IEG), New Delhi
6. Indian Institute of Health Management Research (IIHMR), Jaipur
7. Indian Institute of Technology (IIT), Mumbai
8. National AIDS Research Institute (NARI), Pune
9. Indian Institute of Public Health (IIPH), Bhubaneswar
10. Indian Institute of Technology (IIT), Chennai

PharmD graduates were recognised as eligible personnel for the following scientific and technical positions in these projects:

1. Scientist D (Non - Medical) - Rs. 78,000/- per month + HRA
2. Senior Project Officer/ Senior Research Officer - Rs. 78,000/- per month + HRA
3. Research Officer - depends on project
4. Research Associate - depends on project
5. Field Supervisor - depends on project
6. Field Investigator/ Field Officer - Rs. 30,000 - 32,000/- + HRA

The complete document can be accessed through this weblink: HTAIn ICMR guidelines 2021

Career Opportunities for PharmD Graduates: By recognizing PharmD as an eligibility criterion for scientific positions, governments open up a broader range of career opportunities for PharmD graduates. This move encourages more students to pursue the PharmD program, attracting talented individuals to the pharmacy profession. The availability of government positions creates a positive outlook for aspiring pharmacists and strengthens the profession by acknowledging its significance in public health.

Conclusion: The inclusion of PharmD as an eligibility criterion for government positions is a commendable decision that signifies it's commitment to improving public health. By recognizing the expertise of PharmD graduates and providing them with opportunities to contribute to healthcare policy, medication safety, and interprofessional collaboration, governments pave the way for a more robust and effective healthcare system. This step not only benefits patients but also fosters professional growth, scientific evidence and enhances the role of pharmacists in society. It is imperative to appreciate and support such progressive initiatives that acknowledge the evolving nature of healthcare and the indispensable role of PharmD professionals.

Happy Blogging...!!!

Clinical Pharmacy In India: Insights in an International Magazine

Dear Readers, Thank you for blogging with us. 

I'm glad to share my interview published in an International Magazine "Leckarnicke Listy" in March 2018. 

Thank you #Dr. Peter Krajcovic, PhD for the interview.

Disclaimer: This interview was originally conducted in a foreign language during my visit to a few European countries and it is further translated to the English version, hence English grammatical errors and vocabulary can be exempted. 

How to Use Turnitin : 10 Easy Steps

Turnitin is considered as one of the best online resource for detecting plagiarism. It gives a detailed note on similarity index and the sources utilized for the content plagiarised. Here is a detailed note on How to use Turnitin in 10 Easy steps. 

Dr. Deepak Kumar Bandari, PharmD : Short Profile

Thank you for visiting my blog...!!!

Here you can check out my short profile 

Dr. Deepak Kumar Bandari, PharmD, (PhD) (Europe)

Research Scientist, ICMR-NICPR, Noida.

Current Position: National

1) Project Research Scientist - Indian Council of Medical Research (ICMR) - National Institute of Cancer Prevention and Research (NICPR), Noida and Delhi. 

Project: AccEEND TB, India.

2) Board of Studies Member - Master’s in Clinical Research and Experimental Medicine, School of Allied and Health Sciences, Malla Reddy University, Hyderabad.

3) Book reviewer - BSP Publications, Pharma Med Press and Kakatiya Publications.

Current Position: International
PhD Researcher and Early Stage Researcher participant
Project: FIP 7 programme of EuroAgeism H2020 project, involving 13 European and Non-European countries.

Early-Stage Researcher (ESR) Participant, Euro Ageism H2020, Faculty of Pharmacy in Hradec Králové, Charles University, Europe.

Thesis: Polypharmacy and comparison of differences in potentially inappropriate prescribing in India, Ethiopia, and European countries.
Projects and Grants handled: 

• Project: FIP 7 programme of EuroAgeism H2020 project, involving 13 European and Non-European countries.

Grant: European Commission, FIP7 program Euro Ageism H2020-764632-MSCA-ITN supported by the scientific group “Ageing and Changes in the Therapeutic Values of Drugs in the Aged”, Charles University, Progress Programme Q42, SVV program 260 417.
Total Finance - 232 422,48 EU (Detailed budget - not disclosed)
EU Consortium: Israel, Czech Republic (CZ), UK, Poland, Netherlands, Sweden, Finland, Belgium.
Participating countries: Czech Republic, Serbia, Croatia, Bulgaria, Estonia, Turkey, Spain, Ireland, Belgium, India, Ethiopia.
Collaborating Institutions: Alliance Health and Social Care Alliance Scotland (AL), EMDA – The Alzheimer’s Association Israel (AAI), European Centre for Social Welfare Policy and Research (Euro Centre), National University of Ireland Galway (NUIG), United Nations Economic Commission for Europe (UNECE) and World Health Organization (WHO).

• Project No. START/MED/093

Thesis: Rational geriatric pharmacotherapy, medication errors and clinical pharmacy services in long-term care.
Total Finance - 2,299,968 CZK (Personal cost-1,353,600; Mentor remuneration-40,000; Travel costs-361,000; Training costs- 120,000; Costs of non-investment equipment, materials etc. - 80,000; Overhead costs - 345,368)
Grant: Charles University, Research Unit “Ageing, Polypharmacy and Changes in the Therapeutic Value of Drugs in the AgeD”, United Nations Economic Commission for Europe and World Health Organization, University of Zagreb, Croatia, University of Belgrade.

Previous Positions: National

1)Project Technical Support - III (Field Investigator) - Indian Council of Medical Research (ICMR) - National Institute of Nutrition (NIN), Hyderabad, India. 

Project: Strengthening the Monitoring of Tuberculosis Elimination in India - District Level Sentenial Survey (DLSS), India.

2) Associate Consultant (Epidemiology and Outcomes Research) - Bridge Medical Consulting Pvt. Ltd, New Delhi. 

3) Team Leader - Indian Council of Medical Research (ICMR) – National Institute of Nutrition (NIN), Hyderabad, India.

Project: National Sero-surveillance to monitor the trend of SARS-CoV-2 infection transmission in India.

4) Investigator (Field) - Indian Council of Medical Research (ICMR) – National Institute for Research in Tuberculosis (NIRT), Chennai, India.

Project: National survey for the state-wise prevalence of microbiologically confirmed pulmonary tuberculosis in India.

5) Assistant Professor and Clinical Preceptor: Vaagdevi Institute of Pharmaceutical Sciences, Warangal, India. 

No. of Research Publications: 18
Cumulative Impact Factor: 153
Number of Citations: 3000+

h-index: 14; i-10 index: 15 

Awarded grants: Total 7 (International: 6, National: 1)
Achievements: Total 9 (International: 5, National: 4)
My Interviews in Magazines and Newsletters: 3 (International: 2, National: 1)

Scientific presentations: (International: 11, National: 8)
Book reviews: 9 (International: 2, National: 7)
Guest Lectures: Total 3 (International: 1, National: 2)
Editorial member and reviewer: 8
Certification courses: Total 10 (2 - Stanford University, 8 - National and International Organizations)
Countries affiliated: USA, Italy, Poland, Slovak Republic, The Czech Republic, Germany, Hong Kong and 10 other European countries.

International collaborative research: Early Stage Researcher participant in the FIP 7 programme of EuroAgeism H2020 project under Marie-Curie Innovative Network and EU COST Action IS1402 network aimed at describing main prescribing problems in rational geriatric pharmacotherapy in 13 European and Non- European countries (including India and Ethiopia). 

Collaborating Institutions: Alliance: Health and Social Care Alliance Scotland (AL), EMDA – The Alzheimer’s Association Israel (AAI), European Centre for Social Welfare Policy and Research (EuroCentre), National University of Ireland Galway (NUIG), United Nations Economic Commission for Europe (UNECE) and World Health Organization (WHO).

Remarkable Achievements:

1. Award and Position: Early Stage Researcher (ESR) participant in the network of FIP7 EuroAgeism H2020 – ITN project, European Commission.
2. Reviewer: Acknowledged in Davidson’s Principles and Practice of Medicine textbook, 23rd Edition, 2018; Elsevier publishers ISBN: 9780702070280.
3. Personal interview: “I expect the 8-star Pharmacist Concept of World Health Organization will come true in India in the Future” published in an International Magazine “Lekarnicke Listy”, March 2018, Bratislava, Slovak Republic.
4. Best reviewer award: Textbook of Hutchison’s Clinical Methods 23rd International Edition by Michael Glynn &William Drake. Saunders Publishers, UK ISBN: 978-0-7020-4091
5. ERASMUS+ Student Mobility: Internship in various European countries.

A few other Achievements:

1. Award and Interview: Winner of “Ideathon” First Nobel Prize Series in India, Department of Biotechnology, India. Interview entitled “Pharmacist Nobel Prize Series: Science Impacts Lives – The Pride of India”, Indian Pharmaceutical Association – Community Pharmacy Division (IPA - CPD) e-Times 6 (2), March – April 2017.

2. Story of Success (2017): Published by Elsevier, as a part of the budding Medicos National contest.

3. Elsevier Student Ambassador (ESA) and Mentor’ for South Asia from July 2014 to June 2016.

4. Felicitation and award: Special Faculty Achievement Award at Viswambhara Educational Society Silver Jubilee Celebrations, March 2018, Warangal, India.

5. Award: Pharmacy Practice contribution award on World Pharmacist’s Day, 25th September 2017 for the successful delivery of an invited lecture on the Prescriptive role of Clinical Pharmacist in Ambulatory Care at Deccan School of Pharmacy, Hyderabad, India.

Acknowledgement: 

• I thank Prof. Daniela Fialova, PharmD, PhD, BCCP; Chair of the Horizon 2020 EuroAgeism FIP7 program; Head of the University Centre of Clinical Pharmacy, Faculty of Pharmacy, Charles University; Department of Social and Clinical Pharmacy, Faculty of Pharmacy, Charles University, Department of Geriatrics and Gerontology,1st Faculty of Medicine, Charles University, Czech Republic.
• Dr Akshaya Srikanth Bhagavathula, PharmD, PhD; Associate Professor of Epidemiology, Department of Public Health, North Dakota State University, United States of America. 
• Prof. Yamsani Madhusudan Rao, M.Pharm, PhD; Director, Vaagdevi group of Pharmacy Colleges, Warangal, India for their valuable guidance and support throughout my career.

 

BIRAC Appreciation Grant - 1 Lakh for any graduate

Applications need to be submitted online only. Call for applications will be invited against advertisement by SITARE Partner. Format of application with Statement of Purpose can be accessed through the website. Selected students will be informed 3 weeks prior to the start of the workshop. Tentative months for the conduct of BIIS Workshops: February, June and December.

Process for submitting the proposals online is detailed below: Log on to the BIRAC website www.birac.nic.in

• If you are a registered user, log-in using the credentials, else you need to register yourself as an individual by clicking on New User Registration. In case of new user registration, a computer-generated password would be sent to the email-id provided at the time of registration. 
• The password can be changed later. Once you log in, you would be navigated to the page displaying SITARE-BIIS link. Click on the SITARE-BIIS application link under Programmes and the active call would be highlighted.
• Click on the active call against which you wish to submit the proposal.

Selection will be based on the Statement of Purpose (SoP) submitted by the Student. Key factors for selection of applications include:

• Originality (40%)
• Clarity of Purpose (20%)
• Implementation Plan (15%)
• Potential impact (15%)

For more details check out:  Official website

Research Opportunity in U.S.A: PharmD II to V year Students

As per the information from official sources upon our enquiry it is clear that the students of PharmD II year to V year can apply. 

For more details refer : Official website

Interact with Nobel Laureates in Germany: For Free | Applications Invited

DEPARTMENT OF SCIENCE & TECHNOLOGY (DST) DST-DFG AWARDS FOR PARTICIPATION IN THE 70th MEETING OF NOBEL LAUREATES & STUDENTS 

Lindau, Germany during 28 June–3 July 2020

Exclusive opportunity for young students and researchers to attend meetings include lectures, panel/ round-table discussions with Nobel Laureates in Germany. Every year applications are invited by Department of Science & Technology, India. Interested Indian Nationals can check out all of the details on the same below:

Each year since 1951, Nobel Prize winners in Chemistry, Physics, Physiology or Medicine have been meeting in Lindau, Germany, to discuss major issues of importance to their fields with students from around the world. The meetings include lectures, panel/ round-table discussions on interdisciplinary topics and informal small- group meetings with the Nobel Prize winners. The DST has been sending a group of students/young researchers to these meetings, since 2001. It intended to send a group of Indian Students /young researchers to the 70th Meeting of Nobel Laureates & Students during 28 June–3 July 2020, which is dedicated to multi-disciplinary subjects viz., Physics, Chemistry and Medicine/Physiology.

Applications are invited from bright and young students and researchers in the above disciplines for availing this award. The lectures and discussions are at a level appropriate for students/researchers in their early research careers. More details of the meeting can be seen at www.lindau-nobel.de

Terms of Award: The selected participants will be provided with International travel-related expenses, local transportation, lodging (twin-sharing basis) and boarding for attending the Meeting. It is mandatory for the selected students to attend the complete full week programme in Germany as well as briefing meeting in Delhi prior to departure to Germany. The Indian team of selected students shall leave for Lindau from Delhi (after briefing meeting) and shall return back to Delhi after the completion of the Nobel laureates meeting and the post Lindau Week. Personal or other visits by candidates to institutes other than the scheduled programme during the above period will not be entertained. The selected candidates will have to make their own arrangements for accommodation and transportation in Delhi for attending the briefing meeting at DST prior to the departure to Germany. The charges for accommodation in Delhi and 2nd AC train tickets from the nearest railway station from their places of residence to New Delhi and back will be reimbursed by DST on submission of the receipts/ train tickets as per the DST norms.

It is mandatory that the selected candidates should submit the reports to DST on the Lindau meetings after completion of the programmes and any information document as and when required by DST within the time frame. No escorts/ accompanying persons will be allowed with the participants and no request for personalized programme during this period would be considered in any case. The applicants would also not be allowed to withdraw the nomination after selection.

Eligibility:

i. Only Indian science students (by citizenship) studying/ working/ affiliated to research Institutes/ universities in India are eligible.

ii. Engineering /Tech. students are not eligible.

iii. Indian students studying and doing post-doc/internship/or staying in Germany / abroad are also not eligible for this award.

For more details check out : Official Website

Antibiotics and their Side Effects

Scientific Positions @ National Institute of Biologicals

Scientific Positions @ National Institute of Biologicals

Happy Blogging...!!! For more updates follow us on Facebook

3 crores could be Yours.. Open to all the Pharmacists

Last 5 Days Remaining! Apply Now for National Bio Entrepreneurship Competition (NBEC) 2019, the destination for India's most exciting bio entrepreneurship ideas and be a part of this annual celebration of bio entrepreneurship in India! Stand to win Rs. 3 Crores in cash prizes and investment opportunities!!! What is more, winners will be mentored by leading industry and investment experts. Prizes are up for grabs during regional qualifiers as well!! And shortlisted applicants will attend a 2 day engaging Boot Camp with one-on-one mentoring sessions, led by experts.

So, if you are a student, researcher, innovator, aspiring entrepreneur, start-up, a small or medium biotech company or someone with a bright idea in any discipline of the Life Sciences, here is your chance to win! 

A poster with detailed information is attached. Also look out for new categories that has been added this year, with a bunch of prizes accompanying it.

Apply Here

Applications close on August 31st, 2019, 6 pm.

For detailed information, please visit our Website

About NBEC: The National Bio Entrepreneurship Competition (NBEC) is organised by C-CAMP as part of the BIRAC Regional Entrepreneurship Centre - BREC, every year to attract, identify, and nurture bio-entrepreneurs across India with path-breaking business ideas for societal impact.

PhD program for Qualified Candidates - NIPER, Hyderabad

Opportunities for CSIR/ICMR/DBT/UGC JRF qualified candidates to join NIPER Hyderabad.

Applications are invited from interested, motivated and enthusiastic CSIR/ICMR/DBT/UGC JRF qualified candidates with excellent academic record for the Ph.D. 

Program at NIPER Hyderabad to carry out cutting-edge research in various pharma disciplines for the session 2019-2020. 

Candidates for admission to the Ph.D. program shall have a Master’s degree/ M.Pharm with at least 55% of marks in aggregate or its equivalent grade. 

Eligible candidates may kindly send their resumes enclosed with copies of all relevant certificates to director.niperhyd@gov.in

AIRTF & RTF‐DCS Fellowships - NIPER Hyderabad

NIPER Hyderabad 2nd May 2019 Inviting applications for AIRTF & RTF‐DCS Fellowships NIPER Hyderabad is an established host Institute for AIRTF and RTF DCS, fellowships. 

Applications are invited for the scheme started by Department of Science & Technology (DST), Government of India with Federation of Indian Chambers of Commerce and Industry (FICCI) for the flagship funding program titled “The ASEAN-India Research Training Fellowship (AIRTF)” and “Research Training Fellowship-Developing Countries Scientist” (RTF-DCS). 

Interested candidates may contact/approach Dr Satheesh kumar Nanjappan E-mail: satish.niperhyd@gov.in 

View brochure for more details

Various positions @ NIPER Hyderabad

Dear Readers...!!! Thanks for visiting my blog...!!!

SUMMER INTERNSHIP

NIPER-Hyderabad is an Institute of National Importance in the field of Pharmaceutical Sciences and Management, invites applications from highly motivated and committed students

Departments :

Students for “SUMMER INTERNSHIP” in the following departments.

Medicinal Chemistry

Pharmaceutical Analysis

Pharmacology and Toxicology

Regulatory Toxicology

Pharmaceutics

Process Chemistry

Pharmaceutical Management

Duration of the course::

2 months (1st June - 30th July)

6 months (Preferably 1 st July - 31st December)

Fee structure:

Rs. 10,000/- for 2 months internship

Rs. 25,000/- for 6 months project

Notification commencement: Throughout the year

Application procedure: Click here to apply online

Payment Details:

Mode of Payment: The payment can be made through online.

Bank Account Name: NIPERH RESOURCES

Bank Name: State Bank of India (IDPL Colony Branch)

Bank A/c No.: 37787539689

IFSC Code: SBIN0020245

Eligibility criteria: Students who are pursuing their Graduation/post-graduation and have finished their 1st year of Graduation/Post-graduation (Marks sheet should be enclosed). Pursuing post graduation in the field of Pharmaceutical/Chemical/Life Sciences leading to M.Pharm./M.S./M.Sc/M.Tech/M.B.A degree from any recognized Indian University. Bonafide Certificate from the Head of the Department or Head of the institution.
One Page Curriculum vitae/bio-data of the student

Based on the merit, the students will be shortlisted and intimated via e-mail.
The students need to fill the Application Form for Summer Training available on NIPER website and furnish all relevant information/documents as mentioned in the application form

Note: No accommodation and transportation facility will be provided. The selected candidates have to deposit the fee before joining.

Contact Details:

Dr. N. Shankaraiah, Associate Professor

Phone: +91-40-23074750 (Ext. No: 2021 or 2009)

E-mail.: shankar.niperhyd@gov.in

Proposed Amendments in Pharmacy Practice Regulations - 2015

Dear Readers..!!! Thank you for visiting my blog...!!!

Please find the attached document explaining the proposed amendments to the Pharmacy Practice regulations - 2015 by the Pharmacy Council of India. 

Click here

Let us all hope and try our best for their implementation. Thanks to all the leaders who worked hard for this proposal.

Regards,

Dr. Deepak Kumar Bandari, PharmD,(PhD) (Europe),

Elsevier Student Ambassador and Mentor - South Asia.

Winner - Ideathon - Nobel Prize Series -2017.

Pharmacotherapy Lectures: Need your valuable insights

Dear All PharmD's,
Act today for better tomorrow. Need your valuable support and it's important for a better profession for representation.

Since few years, we are striving for the better profession to become equally competent with the western world. In this regard, we had conversations with our Honorable Prime Minister Shri. Narendra Modi Ji, Central and State Ministries. Our request is accepted and soon the issues of unemployment will be addressed. It is very important for us to even think of the quality of PharmD Education in India.

What have we done till date??
1) We addressed the issue and importance of scholarly research in India and revealed the results for discussion.
2) We addressed the importance of Preceptorship and bedside teaching and discussed with resource persons of American Colleges of Clinical Pharmacy (ACCP), USA.
3) We discussed the issue of unemployment with respective state and Central Ministries, certain issues are already represented by the Central Minister J.P. Nadda in the World Health Assembly.
4) We are also a part of various International Organisations and platforms like ACCP, FIP, USAID, WHO, European Nations, South African, Asian and Gulf Nations representing Indian PharmD globally.
5) We are conducting various interactive programmes among countries and are part of Global research representing Indian PharmD.



What is this initiative about??
As Pharmacotherapy is the soul of PharmD it is important to raise our standards to become enough competent. PharmD is highly sophisticated in the West and hence they've developed 114 Specialities and employed 1000's of Clinical Pharmacists. We are ought to be on the same path and improve our professional standards. Hence we need to know our present education system and quality of Pharmacotherapy lectures. Let us know your valuable inputs by just sparing 5 -10 min, we shall invest our time, money and energy to address your inputs at the right platform for better future.

Why do you need to contribute ??
Excellence comes only when you learn from failures. Tomorrow will be better only if we know the mistakes of today. Unless we come forward and express what we are learning, it cannot be improved. If there is no improvement, there will be no employment.

Being a student how can you contribute ??Simply spare 5 -10min and fill your inputs about the Pharmacotherapy lectures in this survey form. We shall scrutinise, analyse and come out by addressing the flaws with valuable suggestions from experts to update ourselves.

Where is the survey form and is it validated ??
Yes, it has been reviewed by experts from 6 countries and here is the link :

https://ap1trial.qualtrics.com/jfe/form/SV_7O4gvryLLerxkO1

Thanking you in anticipation. Wish you all the best for you future endeavours.

Regards,
Dr. Deepak Kumar Bandari, PharmD,(PhD) Europe
Elsevier Student Ambassador and Mentor - South Asia
Winner - Ideathon - Nobel Prize Series -2017
For more updates join us on Telegram: @drdeepakbandari

Story of Success - Published by Elsevier

Dear Readers,

Thank you for blogging with us. I'm glad to share my story of success published by Elsevier.Thank you #ElsevierIndia for your kind encouragement. 

Nobel Prize Series : India

I'm elated to share an article published regarding my achievement in Indian Pharmaceutical Association (IPA) CPD e-times today, Vol 6, Issue 2, page 12. Thanks to Mrs. Manjiri Gharat, for recognising my efforts and encouraging young pharmacists. Credits: Dr. AkshayaSrikanth, the man behind my success, Prof. Y. Madhusudan Rao, the Legend behind my strength.